Skip to main content
Journal ArticleOPEN ACCESS

STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors

  • Akporiaye E
  • Tucker C
  • Triplett T
  • et al.
Journal for ImmunoTherapy of Cancer (2013) 1(S1)
DOI: 10.1186/2051-1426-1-s1-p68
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Akporiaye, E. T., Tucker, C., Triplett, T., Garrison, K., Sun, L., Ling, L., & Weinberg, A. (2013). STAT3 signaling is required for anti-OX40/TGF-β receptor blockade-mediated regression of large established tumors. Journal for ImmunoTherapy of Cancer, 1(S1). https://doi.org/10.1186/2051-1426-1-s1-p68

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free